Unexpected Toxicities When Nivolumab Was Given as Maintenance Therapy following Allogeneic Stem Cell Transplantation. uri icon

authors

  • Wang, Amy Y
  • Kline, Justin
  • Stock, Wendy
  • Kosuri, Satyajit
  • Andrew Artz, MD, MS
  • Larson, Richard A
  • Riedell, Peter A
  • Bishop, Michael
  • Liu, Hongtao

publication date

  • January 1, 2020